Over the last 7 days, the United States market has remained flat, yet it has risen by an impressive 39% over the past 12 months, with earnings forecasted to grow by 15% annually. In this context of robust growth and stability, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and adaptability within this dynamic sector.
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Super Micro Computer | 21.08% | 28.73% | ★★★★★★ |
Sarepta Therapeutics | 23.80% | 44.01% | ★★★★★★ |
TG Therapeutics | 30.63% | 46.00% | ★★★★★★ |
Ardelyx | 27.19% | 66.44% | ★★★★★★ |
Invivyd | 42.91% | 70.39% | ★★★★★★ |
Amicus Therapeutics | 20.26% | 62.89% | ★★★★★★ |
MediaAlpha | 26.82% | 83.70% | ★★★★★★ |
Travere Therapeutics | 29.32% | 70.79% | ★★★★★★ |
Seagen | 22.57% | 71.80% | ★★★★★★ |
ImmunoGen | 26.00% | 45.85% | ★★★★★★ |
Click here to see the full list of 247 stocks from our US High Growth Tech and AI Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services globally, with a market cap of approximately $14.93 billion.
Operations: The company generates revenue primarily through the development and commercialization of molecular testing services, totaling $1.36 billion.
Natera, a player in the biotech sector, is navigating through its growth phase with significant R&D investments and promising revenue projections. In 2024, the company's R&D expenses were substantial, aligning with its strategic focus on enhancing molecular diagnostic technologies. This investment supports a forecasted annual revenue growth of 13.3%, outpacing the US market average of 8.9%. Moreover, Natera's recent presentation at ESMO highlighted breakthroughs from its GALAXY trial for colorectal cancer, showcasing Signatera's potential to significantly impact patient survival outcomes. These innovations not only underscore Natera’s commitment to advancing healthcare but also position it favorably in a competitive landscape where technological efficacy and advancement drive growth.
Evaluate Natera's historical performance by accessing our past performance report.
Simply Wall St Growth Rating: ★★★★★☆
Overview: PTC Inc. is a software company that operates in the Americas, Europe, and the Asia Pacific with a market capitalization of approximately $22.26 billion.
Operations: PTC generates revenue primarily from its CAD/CAM software segment, which accounts for approximately $2.22 billion.
PTC, amidst the bustling tech landscape, is steering through a transformative phase with a keen focus on R&D, earmarking substantial funds to fuel innovations. In 2024 alone, the company allocated 20.9% of its revenue towards research and development efforts—a strategic move aimed at sharpening its competitive edge in software solutions. This investment underscores PTC's commitment to evolving its technological offerings and maintaining relevance in an industry driven by rapid advancements. Moreover, with recent executive appointments and potential acquisition interests from industry peers like Cadence Design Systems, PTC is poised to leverage its enhanced leadership dynamics and strategic positioning for future growth opportunities.
Understand PTC's track record by examining our Past report.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Zeta Global Holdings Corp. operates an omnichannel data-driven cloud platform offering consumer intelligence and marketing automation software to enterprises globally, with a market cap of approximately $6.39 billion.
Operations: The company generates revenue primarily through its Internet Software & Services segment, amounting to $822.09 million.
Zeta Global Holdings, amidst a challenging tech landscape, is making strategic moves to secure its growth trajectory. With an impressive 16.1% annual revenue growth forecast, Zeta is outpacing the US market average of 8.9%. The company's commitment to innovation is evident in its R&D spending, which significantly contributes to its strategy for turning profitable within the next three years—an expected profit surge of 89.3%. Recent collaborations with Yahoo enhance Zeta's platform capabilities, leveraging AI and data analytics to optimize email marketing strategies and audience targeting, promising a robust integration that could redefine engagement metrics in digital marketing spaces.
Assess Zeta Global Holdings' past performance with our detailed historical performance reports.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:NTRA NasdaqGS:PTC and NYSE:ZETA.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。